News

Gilead Sciences, Inc. (GILD) on Wednesday announced a strategic partnership agreement with the Global Fund to combat AIDS, Tuberculosis, and Malaria by supplying doses of its HIV prevention injection ...
Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...
The human immunodeficiency virus type 1 (HIV-1) is the etiological agent of one of the most threatening human diseases, referred to as acquired immune deficiency syndrome (AIDS). Currently, there are ...